UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

Re-live UEG Week 2026 on Gutflix Gut Guide online What's new on Gutflix

Trending on Gutflix

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

PREVALENCE OF SEXUAL DYSFUNCTION IN PATIENTS WITH LIVER DISEASE

Arafat Ali Taher ALRAEEINI 1, Manal Cherkaoui Malki 2, Salma Mechhor 3, Nadia Benzzoubeir 1, Ikram Errabih 4, Hicham El Bacha 5

Affiliations

1 Faculty Of Medicine And Pharmacy - Mohammed V University, Rabat, Morocco

2 University Hospital Ibn Sina, Rabat, Morocco

3 Ibn Sina Hospital, Rabat, Morocco

4 Ibn Sina University Hospital, Rabat, Morocco

5 Hopital ibn sina / universite mohamed v / faculte de medecine, Rabat, Morocco

Summary

AI Generated

A 2023 monocentric study of 120 male patients found significantly higher rates of sexual dysfunction across all domains in those with chronic liver disease compared to controls, with cirrhosis identified as the only statistically significant risk factor.

Male patients with chronic liver disease (n=60) had significantly higher rates of erectile dysfunction (66.6% vs 26.6%, p=0.003), orgasmic dysfunction (58.3% vs 23.3%, p=0.012), disorders of desire (68.3% vs 16.6%, p<0.001), disorders of sexual satisfaction (63.3% vs 30%, p<0.001), and disorders of overall satisfaction (75% vs 28.3%, p<0.001) compared to controls without liver pathology (n=60).
Cirrhosis was the only statistically significant risk factor for sexual dysfunction identified in the study (OR 7.9, p=0.012), and 65% of the liver disease cohort were cirrhotics.
All patients (100%) reported never having been asked about their sexual health during a consultation.
The authors conclude that sexual dysfunction should be systematically screened in liver disease patients with a multidisciplinary approach to management.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Chronic liver disease, particularly cirrhosis, leads to significant morphological and psychological endocrine changes, which can have an impact on patients' sexual health. Although sexual health is an important parameter of quality of life, it remains little studied in hepatology.

Aims & Methods

The aim of our work is to study the prevalence and degree of sexual dysfunction in male patients with chronic liver disease, and the associated risk factors.
This is a monocentric, comparative, descriptive and analytical study conducted during the year 2023.We included male patients followed for chronic hepatopathies (group 1 (G1)) as well as a control group of subjects followed in gastroenterology consultation presenting no hepatic pathology (group 2(G2)). Exclusion criteria were the existence of overt hepatic encephalopathy, cognitive disorders or active alcohol abuse, limiting the reliability of the survey.
Sexual health was assessed using the IIEF (International Index of Erectile Function) questionnaire, which covers five domains: erection, orgasm, desire, satisfaction with intercourse and overall satisfaction. Two software packages were used for statistical analysis: Jamovi version 2.3.28 and Microsoft Excel.

Results

Our study included 120 patients, 60 followed for chronic liver disease, and 60 without liver pathology (control group).
Mean age was 44.6 years (21-73 years).
In the group of patients with hepatopathies, we found:
34 (65%) cirrhotics, 24 (40%) of whom had a history of decompensation.
18 (30%) HBV, 11(18%) HCV, 5 (8%) NAFLD, 5 (8%) of undetermined cause, 5 (8%) portal hypertension, 4 (6.6%) portal thrombosis, 12 (19.8%) others.
Patients in the liver disease group had more erectile dysfunction, orgasmic dysfunction, disorders of desire, disorders of sexual satisfaction and disorders of overall satisfaction compared with the control group, with respectively 40/60 (66. 6%) vs 16/60 (26.6%) p 0.003; 35/60 (58.3%) vs 14/60 (23.3%) p 0.012; 41/60 (68.3%) vs 10/60 (16.6) p <.001; 38/60 (63.3%) vs 18/60 (30%) p <.001; and 45/60 (75%), vs 17/60 (28.3%) p <.001.
After statistical analysis, cirrhosis was the only statistically significant risk factor for sexual dysfunction in our study (OR 7.9 ;p 0.012).
Moreover, 100% of patients said they had never been asked about their sexual health during a consultation.

Conclusion

Sexual dysfunction is common in patients followed for liver disease, with cirrhosis as the main risk factor. Sexual dysfunction should be systematically screened, with a multidisciplinary approach to the management of these patients.

Conference

UEG Week Vienna 2024

Topics

Hepatobiliary

Submission format

Abstract

Session

LIVER (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

When the acid is gone: Dealing with gastric atrophy

Marco Vincenzo Lenti

Can surgery be the cure?

Gianluca M Sampietro

Life after liver transplant

Gonzalo Crespo

DOES DOSE MATTER? OUTCOMES FOLLOWING TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB FROM THE IRESWITCH STUDY

Glen Doherty

NOT ALL NORMAL POUCHES ARE ALIKE: THE CLINICAL AND MICROBIAL SPECTRUM OF DURABLE NORMAL POUCH BEHAVIOR

Iris Dotan

Leadership in crisis with Axel Dignass

Axel Dignass

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

When the acid is gone: Dealing with gastric atrophy

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.